This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Fracture Intervention Trial

Authoring team

A randomized, double-blind, placebo controlled trial (Fracture intervention Trial FIT) performed by Black et al (Lancet 1996) has revealed that alendronate safely reduced the frequency of vertebral and nonvertebral fractures in postmenopausal women with low bone mass density.

1022 women were assigned to the alendronate (treatment group) and 1005 women were assigned to placebo.

  • women receiving alendronate increased mean bone mass measured at the femoral neck, total hip, posterior-anterior lumbar spine, whole body and proximal forearm. Eight per cent of the treatment group (compared to 15% in the placebo group) had >=1 vertebral fracture

Reference:

  • Black DM et al (1996), Lancet, 348, 1535-41.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.